Revlimid 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg hard capsules
*Company:
Bristol-Myers Squibb Pharma EEIGStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Patient Pocket Information Card
Risk Minimisation Materials
(Click to Download) Community Pharmacy Dispensing Notification Form
Risk Minimisation Materials
(Click to Download) Healthcare Professional Information Guide
Risk Minimisation Materials
(Click to Download) Order Form
Risk Minimisation Materials
(Click to Download) Pharmacy Registration Form
Risk Minimisation Materials
(Click to Download) Prescription Authorisation Form
Risk Minimisation Materials
(Click to Download) Male Risk Awareness Form
Risk Minimisation Materials
(Click to Download) Woman of Childbearing Potential Risk Awareness Form
Risk Minimisation Materials
(Click to Download) Woman of Non-Childbearing Potential Risk Awareness Form
Risk Minimisation Materials
(Click to Download) Healthcare Professionals' Information Pack for Prescribers
Risk Minimisation Materials
(Click to Download) Healthcare Professionals' Information Pack for Pharmacists
Risk Minimisation Materials
(Click to Download) Healthcare Professionals' Information Full Pack
Risk Minimisation Materials
Bristol-Myers Squibb Pharma EEIG
Address:
Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, IrelandMedical Information E-mail:
medical.information@bms.comTelephone:
+353 1 483 3625Medical Information Direct Line:
Freephone 1 800 749 749Stock Availability:
bmscustomer-service.chester@bms.com